• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性死亡配体1(PD-L1)是浸润性乳腺癌中调节性B细胞和T细胞的关键介质。

PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.

作者信息

Guan Honggeng, Wan Yuqiu, Lan Jing, Wang Qin, Wang Zhangyu, Li Yecheng, Zheng Jiqing, Zhang Xueguang, Wang Zemin, Shen Yueping, Xie Fang

机构信息

The Department of Pathology, Medical College of Soochow University, 199 Renai Road, Suzhou, 215123, P. R. China.

Department of General Surgery, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, P. R. China.

出版信息

Sci Rep. 2016 Oct 20;6:35651. doi: 10.1038/srep35651.

DOI:10.1038/srep35651
PMID:27762298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5071845/
Abstract

Regulatory T cells (Tregs), a key mediator in regulating anti-tumor immune suppression, tumor immune escape, metastasis and relapse, are considered an important therapeutic target in immunotherapy of human cancers. In the present investigation, elevated CD19 CD24 CD38 regulatory B cells (Bregs) were observed in PBMCs of invasive carcinoma of breast (IBCa) patients compared with that in patients with fibroadenoma (FIBma) or healthy individuals, and the positive correlation existed between Bregs and CD4 CD25 CD127 Tregs (r = 0.316, P = 0.001). We found that PD-L1 expression was higher on Bregs in IBCa patients compared with patients with FIBma or healthy individuals (P < 0.05, respectively), and that a tight correlation exists between CD19 CD24 CD38 PD-L1 Bregs and CD19 CD24 CD38 Bregs (r = 0.267, P = 0.007), poor TNM phases and up-regulated expression of PD-L1 on Bregs. The pattern of PD-1 expression on CD4 T cells indicated that high level of PD-1 expressed on CD4 CD25 CD127 effector T cells (P < 0.001). More importantly, the presence of PD-L1 on Bregs was positively correlated with Tregs (r = 0.299, P = 0.003), but negatively correlated with PD-1 effector T cells (r = -0.22, P = 0.031). Together, results of the present study indicated that PD-L1 is an important molecule on Bregs, mediated the generation of Tregs in IBCa.

摘要

调节性T细胞(Tregs)是调节抗肿瘤免疫抑制、肿瘤免疫逃逸、转移和复发的关键介质,被认为是人类癌症免疫治疗的重要靶点。在本研究中,与纤维腺瘤(FIBma)患者或健康个体相比,浸润性乳腺癌(IBCa)患者外周血单个核细胞(PBMCs)中CD19 CD24 CD38调节性B细胞(Bregs)升高,且Bregs与CD4 CD25 CD127 Tregs之间存在正相关(r = 0.316,P = 0.001)。我们发现,与FIBma患者或健康个体相比,IBCa患者Bregs上的PD-L1表达更高(P分别< 0.05),且CD19 CD24 CD38 PD-L1 Bregs与CD19 CD24 CD38 Bregs之间存在紧密相关性(r = 0.267,P = 0.007),TNM分期较差且Bregs上PD-L1表达上调。CD4 T细胞上PD-1的表达模式表明,CD4 CD25 CD127效应T细胞上表达高水平的PD-1(P < 0.001)。更重要的是Bregs上PD-L1的存在与Tregs呈正相关(r = 0.299,P = 0.003),但与PD-1效应T细胞呈负相关(r = -0.22,P = 0.031)。总之,本研究结果表明PD-L1是Bregs上的重要分子,介导了IBCa中Tregs的产生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/59b475d361a7/srep35651-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/62144e8fcc64/srep35651-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/102c5f182e52/srep35651-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/4df7577eb664/srep35651-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/59b475d361a7/srep35651-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/62144e8fcc64/srep35651-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/102c5f182e52/srep35651-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/4df7577eb664/srep35651-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/babc/5071845/59b475d361a7/srep35651-f4.jpg

相似文献

1
PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.程序性死亡配体1(PD-L1)是浸润性乳腺癌中调节性B细胞和T细胞的关键介质。
Sci Rep. 2016 Oct 20;6:35651. doi: 10.1038/srep35651.
2
The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1 regulator B cells mediates immunosuppression in triple-negative breast cancer.可溶性程序性死亡配体-1(sPD-L1)与 PD-1 调节性 B 细胞之间的相互作用介导三阴性乳腺癌的免疫抑制。
Front Immunol. 2022 Jul 22;13:830606. doi: 10.3389/fimmu.2022.830606. eCollection 2022.
3
PD-L1 Regulatory B Cells Are Significantly Decreased in Rheumatoid Arthritis Patients and Increase After Successful Treatment.PD-L1 调节性 B 细胞在类风湿关节炎患者中显著减少,并在成功治疗后增加。
Front Immunol. 2018 Oct 1;9:2241. doi: 10.3389/fimmu.2018.02241. eCollection 2018.
4
The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19 CD25 Bregs and suppresses the secretion of IL-10 in patients with allergic rhinitis.阻断 PD-1/PD-L1 通路可促进变应性鼻炎患者 CD19 CD25 Bregs 的凋亡,并抑制其 IL-10 的分泌。
Scand J Immunol. 2020 Feb;91(2):e12836. doi: 10.1111/sji.12836. Epub 2019 Nov 3.
5
IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.产生白细胞介素-10的调节性B细胞在慢性乙型肝炎病毒感染中抑制效应T细胞,但增强调节性T细胞。
Clin Sci (Lond). 2016 Jun 1;130(11):907-19. doi: 10.1042/CS20160069. Epub 2016 Mar 15.
6
Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.在复发型多发性硬化症患者中,阿仑单抗治疗后调节性 B 细胞缺陷的恢复。
J Neuroinflammation. 2018 Oct 30;15(1):300. doi: 10.1186/s12974-018-1334-y.
7
CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.肾移植受者中的CD4+CD25+CD127-Foxp3+和CD8+CD28-T调节性T细胞:表型模式、与免疫抑制药物的关联以及与效应性CD8+T细胞和CD19+IL-10+B调节性细胞的相互作用
Front Immunol. 2021 Jul 15;12:716559. doi: 10.3389/fimmu.2021.716559. eCollection 2021.
8
PD-L1 mediated the differentiation of tumor-infiltrating CD19 B lymphocytes and T cells in Invasive breast cancer.PD-L1 介导浸润性乳腺癌中肿瘤浸润性 CD19+B 淋巴细胞和 T 细胞的分化。
Oncoimmunology. 2015 Aug 12;5(2):e1075112. doi: 10.1080/2162402X.2015.1075112. eCollection 2016 Feb.
9
Differences of Circulating CD25 Bregs and Their Correlations with CD4 Effector and Regulatory T Cells in Autoantibody-Positive T1D Compared with Age-Matched Healthy Individuals.与年龄匹配的健康个体相比,自身抗体阳性 T1D 患者外周血 CD25+Bregs 的差异及其与 CD4 效应和调节性 T 细胞的相关性。
J Immunol Res. 2022 Jan 17;2022:2269237. doi: 10.1155/2022/2269237. eCollection 2022.
10
Loss of Gαq impairs regulatory B-cell function.Gαq 缺失会损害调节性 B 细胞的功能。
Arthritis Res Ther. 2018 Aug 24;20(1):186. doi: 10.1186/s13075-018-1682-0.

引用本文的文献

1
Elucidating DNA Damage-Dependent Immune System Activation.阐明DNA损伤依赖性免疫系统激活。
Int J Mol Sci. 2025 Jun 18;26(12):5849. doi: 10.3390/ijms26125849.
2
PD-L1 Regulatory B Cells from Rheumatoid Arthritis Patients Have Impaired Function in Suppressing IFN-ү and IL-21 Production.类风湿关节炎患者的PD-L1调节性B细胞在抑制IFN-γ和IL-21产生方面功能受损。
Int J Mol Sci. 2025 Mar 25;26(7):2998. doi: 10.3390/ijms26072998.
3
Cross-Talk Between Cancer and Its Cellular Environment-A Role in Cancer Progression.癌症与其细胞微环境之间的相互作用——在癌症进展中的作用

本文引用的文献

1
PD-L1 mediated the differentiation of tumor-infiltrating CD19 B lymphocytes and T cells in Invasive breast cancer.PD-L1 介导浸润性乳腺癌中肿瘤浸润性 CD19+B 淋巴细胞和 T 细胞的分化。
Oncoimmunology. 2015 Aug 12;5(2):e1075112. doi: 10.1080/2162402X.2015.1075112. eCollection 2016 Feb.
2
Immune Checkpoint Inhibitors: Therapeutic Tools for Breast Cancer.免疫检查点抑制剂:乳腺癌的治疗工具
Asian Pac J Cancer Prev. 2016;17(3):905-10. doi: 10.7314/apjcp.2016.17.3.905.
3
Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapy.
Cells. 2025 Mar 10;14(6):403. doi: 10.3390/cells14060403.
4
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy.调节性细胞在乳腺癌中的复杂作用:对免疫发病机制和免疫治疗的影响
Breast Cancer. 2025 Mar;32(2):227-241. doi: 10.1007/s12282-024-01654-7. Epub 2024 Nov 26.
5
Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches.探究乳腺癌的肿瘤免疫原性:解析肿瘤免疫应答以增强治疗方法。
Front Immunol. 2024 Oct 23;15:1399754. doi: 10.3389/fimmu.2024.1399754. eCollection 2024.
6
Optimized full-spectrum flow cytometry panel for deep immunophenotyping of murine lungs.优化的全谱流式细胞术面板用于深度免疫表型分析小鼠肺部。
Cell Rep Methods. 2024 Nov 18;4(11):100885. doi: 10.1016/j.crmeth.2024.100885. Epub 2024 Oct 30.
7
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.系统分析显示,ER+ 乳腺癌患者血液中的细胞因子信号反应经常失调。
NPJ Syst Biol Appl. 2024 Oct 10;10(1):118. doi: 10.1038/s41540-024-00447-0.
8
The Current and Future of Biomarkers of Immune Related Adverse Events.免疫相关不良事件生物标志物的现状和未来。
Rheum Dis Clin North Am. 2024 May;50(2):201-227. doi: 10.1016/j.rdc.2024.01.004. Epub 2024 Mar 12.
9
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood.系统分析揭示了雌激素受体阳性(ER+)乳腺癌患者血液中细胞因子信号传导反应反复失调。
bioRxiv. 2023 Nov 3:2023.10.31.564987. doi: 10.1101/2023.10.31.564987.
10
Effect of IL-10-producing B cells in peripheral blood and tumor tissue on gastric cancer.外周血和肿瘤组织中产生 IL-10 的 B 细胞对胃癌的影响。
Cell Commun Signal. 2023 Nov 9;21(1):320. doi: 10.1186/s12964-023-01174-5.
程序性死亡-1/程序性死亡配体-1信号通路及其在丙型肝炎病毒免疫治疗中的阻断作用
World J Hepatol. 2015 Oct 18;7(23):2449-58. doi: 10.4254/wjh.v7.i23.2449.
4
Regulatory B cell: New member of immunosuppressive cell club.调节性B细胞:免疫抑制细胞群体的新成员。
Hum Immunol. 2015 Sep;76(9):615-21. doi: 10.1016/j.humimm.2015.09.006. Epub 2015 Sep 15.
5
B Cells with Regulatory Function in Animal Models of Autoimmune and Non-Autoimmune Diseases.自身免疫性和非自身免疫性疾病动物模型中具有调节功能的B细胞。
Open J Immunol. 2015 Mar;5(1):9-17. doi: 10.4236/oji.2015.51002.
6
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival.程序性死亡受体1(PD-1)的表达定义了滤泡性淋巴瘤中两个不同的T细胞亚群,它们对患者生存的影响存在差异。
Blood Cancer J. 2015 Feb 20;5(2):e281. doi: 10.1038/bcj.2015.1.
7
PD-L1hi B cells are critical regulators of humoral immunity.PD-L1hi B 细胞是体液免疫的关键调节者。
Nat Commun. 2015 Jan 22;6:5997. doi: 10.1038/ncomms6997.
8
CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.人类慢性移植物抗宿主病中的 CD24(hi)CD27⁺ 和浆母细胞样调节性 B 细胞。
Blood. 2015 Mar 12;125(11):1830-9. doi: 10.1182/blood-2014-09-599159. Epub 2015 Jan 20.
9
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
10
Regulatory B cells in experimental mouse models of arthritis.关节炎实验小鼠模型中的调节性B细胞。
Methods Mol Biol. 2014;1190:183-94. doi: 10.1007/978-1-4939-1161-5_13.